Regulatory scrutiny has intensified, and the FDA has stepped in to limit many uses
SubQ glutathione has a compelling mechanism, combined with widepsread off-label use and a possible pharmacokinetic advantage over oral glutathione
On April 1, 2026, the FDA reiterated its enforcement policy: it does not currently intend to take action where a 503A compounder fills four or fewer prescriptions per calendar month of a drug that is "essentially a copy." That safe harbor is narrow, and it signals the FDA's direction
Its Drug Affinity Complex (DAC) moiety binds to serum albumin, extending its half-life to approximately 68 days and producing sustained, dose-dependent elevations in GH and IGF-1 [1]
Deficiency Symptoms Men and women fed intravenously (IV) with solutions that contained adequate methionine and folate but lacked choline have been found to develop a condition called nonalcoholic fatty liver disease (NAFLD) and signs of liver damage that resolved when choline was provided (12)